Zai Lab Ltd
ZLAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001704292
In the last 90 days, Zai Lab Ltd insiders filed 1 open-market purchase and 7 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $822.8M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Zai Lab Ltd as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 92
- −6 vs. Q1 2026
- Shares held
- 43.3M
- +15.1M (+53.3%) vs. Q1 2026
- Total value
- $822.8M
- +$291.9M (+55.0%) vs. Q1 2026
- New holders
- 15
- 28 more added
- Sold out
- 21
- 29 more reduced
1 institution that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZLAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 92 | $822.8M |
| Q1 2026 | 99 | $530.9M |
| Q4 2025 | 126 | $510.5M |
| Q3 2025 | 138 | $1.19B |
| Q2 2025 | 156 | $1.49B |
| Q1 2025 | 160 | $1.97B |
| Q4 2024 | 131 | $1.48B |
| Q3 2024 | 104 | $1.10B |
| Q2 2024 | 105 | $707.8M |
| Q1 2024 | 117 | $668.9M |
| Q4 2023 | 124 | $1.13B |
| Q3 2023 | 122 | $954.6M |
| Q2 2023 | 138 | $1.18B |
| Q1 2023 | 161 | $1.85B |
| Q4 2022 | 167 | $1.79B |
| Q3 2022 | 171 | $2.11B |
| Q2 2022 | 166 | $2.11B |
| Q1 2022 | 176 | $2.74B |
| Q4 2021 | 207 | $4.07B |
| Q3 2021 | 228 | $6.76B |
| Q2 2021 | 234 | $11.0B |
| Q1 2021 | 222 | $7.24B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Zai Lab Ltd; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −14,529−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −14,300−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −10,694−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,019−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −5,799−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −5,400−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −1,004−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −33−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| CWM, LLC | – | – | – | – | Not filed |